Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models. - Ting-Yu Chang; Yan Yan; Zih-Yao Yu; Rathore, Moeez; Nian-Zhe Lee; Hui-Ju Tseng; Li-Hsin Cheng; Wei-Jan Huang; Wei Zhang; Chan, Ernest R.; Yulan Qing; Ming-Lun Kang; et al. (Journal of Clinical Investigation, 2024)